Guidelines for treating paediatric opportunistic infections released Guideline 30 January 2013 Pages: 2 - 2
UK NHS should consider paying top dollar for rare disease drugs Media release 30 January 2013 Pages: 2 - 2
Paediatric `flu vaccination does not spare household costs Clinical study 30 January 2013 Pages: 4 - 4
Inappropriate prescribing linked to hospitalisation, death in elderly Clinical study 30 January 2013 Pages: 5 - 5
Ximelagatran value depends on intracranial haemorrhage risk Clinical study 30 January 2013 Pages: 5 - 5
Activities to promote quality use of medicines in New Zealand Clinical study 30 January 2013 Pages: 6 - 6
Assessing the cost effectiveness of routine screening for HIV infections News item 30 January 2013 Pages: 6 - 6
Potential HCV vaccine “highly economically attractive” in Canada Clinical study 30 January 2013 Pages: 7 - 7
IVIG therapy best bet for neonatal alloimmune thrombocytopenia Clinical study 30 January 2013 Pages: 9 - 9
Antibacterial use rising in Danish hospitals despite guidelines Clinical study 30 January 2013 Pages: 10 - 10
Pneumatic compression worth considering at caesarean section Clinical study 30 January 2013 Pages: 10 - 10
US Medicaid eligibility, costs low in Hispanic patients with SLE Clinical study 30 January 2013 Pages: 10 - 10
Concerns over opioid analgesic use in spinal pain not warranted Clinical study 30 January 2013 Pages: 11 - 11
Transdermal contraceptive patch a cost-saving option in the US Clinical study 30 January 2013 Pages: 11 - 11
Antibacterial use, resistance varied and concerning in Europe News item 30 January 2013 Pages: 12 - 12
Aspirin use in diabetes mellitus remains suboptimal in the US Clinical study 30 January 2013 Pages: 12 - 12
Computerised decision support tool helps cut medical errors, costs Media release 30 January 2013 Pages: 12 - 12
Inpatient IV anticoagulation therapy “prohibitively expensive” Clinical study 30 January 2013 Pages: 12 - 12
Dutch patients “very satisfied” with solifenacin succinate Clinical study 30 January 2013 Pages: 13 - 13
Gefitinib significantly improves symptoms, QOL in NSCLC Clinical study 30 January 2013 Pages: 13 - 13
Q-TWiST favours epirubicin-containing regimen in breast cancer Clinical study 30 January 2013 Pages: 13 - 13
Patent expiries, generic competition to hit pharma hard by 2008 News item 30 January 2013 Pages: 14 - 14